Since joining IDEC in 1992, Matsui was employed as senior vice president of its investor relations, corporate communications, human resources, project management and strategic planning; collaboration chair for the late stage development and commercialization of rituximab as well as project leader for the radioimmunotherapy
Verastem announced that the results of the Phase 2 DYNAMO study, which evaluated COPIKTRA capsules in patients with indolent non-Hodgkin lymphoma who were refractory to both rituximab and chemotherapy or radioimmunotherapy
, was published online in the Journal of Clinical Oncology.
of hepatocellular carcinoma with iodine (1311) metuximab injection: clinical phase I/II trials.
However, the science behind radioimmunotherapy
is based primarily on data from animal models and has not been fully evaluated in patients.
Given the poor prognosis, there are several ongoing clinical trials investigating other agents, such as Irinotecan, Temozolomide and Bevacizumab in Combination with Existing High Dose Alkylator Based Chemotherapy and Phase I Trial of Intraperitoneal Radioimmunotherapy
with [sup.131]I-8H9 [25, 26].
Batra, "Optimization of radioimmunotherapy
of solid tumors: biological impediments and their modulation," Clinical Cancer Research, vol.
Niessner et al., "Repeated adjuvant anti-CEA radioimmunotherapy
after resection of colorectal liver metastases: safety, feasibility, and long-term efficacy results of a prospective phase 2 study," Cancer, vol.
Surgery, chemotherapy, radiotherapy, and radioimmunotherapy
are different weapons to fight with GI lymphoma .
In the case of radioimmunoconjugates, a multistep pretargeted radioimmunotherapy
approach that employs GD2-specific antibody-streptavidin constructs is justified.
Visit Monoclonal Antibody Therapeutics Market by Source Type (Chimeric and Humanized, Human, Murine, Others), Therapy Type (Antibody-Directed Enzyme Prodrug Therapy, Antibody-Drug Conjugates, Radioimmunotherapy
), Application (Autoimmune Diseases, Cancer, Hematological Diseases, Infection, Ophthalmological Diseases, Others), and End User (Hospitals, Private Clinics, Research Institutes) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/monoclonal-antibody-therapeutics-market/
PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy
in a child with neuroblastoma.